Steinitz, Katharina Nora,Wilhelmina Van Helden, Paula Maria,Reipert, Birgit Maria,Schwarz, Hans-Peter,Ehrlich, Hartmut
申请号：
AU2016202155
公开号：
AU2016202155B2
申请日:
2016.04.06
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
#$%^&*AU2016202155B220180201.pdf#####ABSTRACT [0255] The present invention is related to peptides that can be used to reduce the immune response against FVIII or to induce tolerance to human FVIII in patients with, e.g., haemophilia A. Furthermore, the peptides can be used for immunodiagnostic purposes to detect FVIII-specific CD4+ T cells to monitor patients with haemophilia A during replacement therapy and during immune tolerance induction therapy.
